Cecilia Hoffman
Impact in
- Biotechnology top 0.5%
- Microbial Metabolism and Applications
- Pharmacology top 2%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
- Pharmacological Effects of Natural Compounds
Papers in
-
- Metabolism, Diabetes, and Cancer 1
- Plant biochemistry and biosynthesis 1
-
- Hormonal and reproductive studies 1
- Co-authors
- Jerrold M. Liesch (1 shared paper)Richard L. Monaghan (1 shared paper)E. O. Stapley (1 shared paper)G. W. Kuron (1 shared paper)G. Albers‐Schönberg (1 shared paper)Arthur A. Patchett (1 shared paper)Alfred W. Alberts (1 shared paper)V. M. Hunt (1 shared paper)
- Journals
- Journal of the American College of Cardiology (1 paper)The Lancet (1 paper)Diabetes Care (1 paper)Metabolism (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesArgentina
In The Last Decade
Cecilia Hoffman
7 papers receiving 1.3k citations
Cecilia Hoffman's Hit Papers
Peers
Comparison fields: 5 of 92
- Biotechnology 706
- Pharmacology 537
- Pharmacology 112
- Biochemistry 75
- Molecular Biology 812
Countries citing papers authored by Cecilia Hoffman
This map shows the geographic impact of Cecilia Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Hoffman more than expected).
Fields of papers citing papers by Cecilia Hoffman
This network shows the impact of papers produced by Cecilia Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Hoffman. The network helps show where Cecilia Hoffman may publish in the future.
Co-authors
The 25 scholars most cited alongside Cecilia Hoffman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Hit paper breakdown → | 1980 | 1298 |
| 2 | 1971 | 29 | |
| 3 | 1973 | 24 | |
| 4 | 1982 | 15 | |
| 5 | 1972 | 8 | |
| 6 | 1995 | 4 | |
| 7 | 1973 | 1 |
About Cecilia Hoffman
Cecilia Hoffman is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Pharmacology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 7 papers that have together received 1.4k indexed citations. Recurring topics across this work include Soft tissue tumor case studies (1 paper), Metabolism, Diabetes, and Cancer (1 paper), Effects and risks of endocrine disrupting chemicals (1 paper), Plant biochemistry and biosynthesis (1 paper), Microbial Metabolism and Applications (1 paper), Hormonal and reproductive studies (1 paper), Pharmacology and Obesity Treatment (1 paper) and Pulmonary Hypertension Research and Treatments (1 paper). The work is most often cited by research in Biotechnology (706 citations), Pharmacology (537 citations), Pharmacology (112 citations), Biochemistry (75 citations) and Molecular Biology (812 citations). Cecilia Hoffman has collaborated with scholars based in United States and Argentina. Frequent co-authors include Jerrold M. Liesch, Richard L. Monaghan, E. O. Stapley, G. W. Kuron, G. Albers‐Schönberg, Arthur A. Patchett, Alfred W. Alberts, V. M. Hunt, E. J. Harris and Susan Currie. Their work appears in journals such as Journal of the American College of Cardiology, The Lancet, Diabetes Care, Metabolism and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.